Subsequently, one of these altered pseudogenes termed DUXAP10 is frequently overexpressed in multiple cancers including liver hepatocellular carcinoma, bladder cancer, esophageal Cancer, and gastric cancer tissues. The gene discussed is DUXAP10; the disease is urinary bladder carcinoma.